Awarded Contractocds-r6ebe6-0000737956
NP92619 ERT Medicines
NP92619 ERT Medicines
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£9,709,875
Published
18 Jul 2023
Closes
18 Jul 2023
Procurement details
Source
Pcs
Region
Scotland
Procurement method
Not provided
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 NP92619 ERT Medicines
£9,709,875
The following Framework Agreements have been extended and are for the supply of the following ERT Medicines to NHS Scotland: NP92619 (e) - Velaglucerase alfa - VPRIV®, NP92619 (f) - Idursulfase - Elaprase®, NP92619 (g) - Agalsidase Alfa - Replagal®.
Delivery: Scotland
Documents
Unlock document linkNP92619 ERT Medicines
Not provided
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.